Changes in bone mineral density during therapy in childhood acute lymphoblastic leukemia

Indian Pediatr. 2009 Mar;46(3):245-8. Epub 2009 Jan 21.

Abstract

Quantitative computed tomography was performed to determine bone mineral density (BMD) at initial presentation and following 6-months of therapy in children with acute lymphoblastic leukemia (ALL). Of 46 children enrolled, the complete set of observations was available in 32. The combined mean BMD of three lumbar vertebrae at diagnosis and during treatment were 167.1+/-27.4 and 148.8+/-31.4 mg/ cm3, respectively (P=0.001). Twenty six children (81.2%) had a decrease in BMD on treatment. The mean BMD for each of 3 vertebrae declined as well. The mean T-scores at diagnosis and during therapy were -0.15+/-0.9 and -0.86+/-1.0, respectively (P=0.001). Conventional radiographs revealed metaphyseal lucencies which were replaced with metaphyseal dense bands with therapy. To conclude, there was a significant reduction of BMD in children with ALL following 6- months of treatment.

MeSH terms

  • Absorptiometry, Photon
  • Antineoplastic Agents, Hormonal / administration & dosage
  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Density / drug effects*
  • Bone Density / radiation effects
  • Child, Preschool
  • Dexamethasone / administration & dosage
  • Female
  • Humans
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnostic imaging
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Prednisone / administration & dosage
  • Prospective Studies
  • Tomography, X-Ray Computed
  • Vincristine / administration & dosage

Substances

  • Antineoplastic Agents, Hormonal
  • Antineoplastic Agents, Phytogenic
  • Vincristine
  • Dexamethasone
  • Prednisone